Diabetic Investor has just received word that the FDA has finally approved the iBGStar glucose monitor. The iBGStar is the first FDA approved glucose monitor that attaches the popular iPhone and marks the beginning of Sanofi’s (NYSE:SNY) entry into the highly competitive glucose monitoring market. Besides the iBGStar Sanofi will also offer the BGStar a more conventional stand-alone meter. Both meters came from Sanofi’s partnership with privately held AgaMatrix and should provide a much need boost for the company which has struggled to find a following.
With this approval we’ll finally see if iPhone users . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.